References
[1]
Chen
W,
Zheng
R,
Baade
P D, et al.
Cancer statistics in China, 2015.
CA Cancer J Clin,
2016, 66: 115-132
Google Scholar
http://scholar.google.com/scholar_lookup?title=Cancer statistics in China, 2015&author=Chen W&author=Zheng R&author=Baade P D&publication_year=2016&journal=CA Cancer J Clin&volume=66&pages=115-132
[2]
Rosenberg
S A,
Lotze
M T,
Muul
L M, et al.
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
N Engl J Med,
1985, 313: 1485-1492
Google Scholar
http://scholar.google.com/scholar_lookup?title=Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer&author=Rosenberg S A&author=Lotze M T&author=Muul L M&publication_year=1985&journal=N Engl J Med&volume=313&pages=1485-1492
[3]
Breakthrough of the year 2013. How we did in 2013 and ······.
Science,
2013, 342: 1442
Google Scholar
http://scholar.google.com/scholar_lookup?title=Breakthrough of the year 2013. How we did in 2013 and ······&publication_year=2013&journal=Science&volume=342&pages=1442
[4]
Porter
D L,
Levine
B L,
Kalos
M, et al.
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia.
N Engl J Med,
2011, 365: 725-733
CrossRef
PubMed
Google Scholar
http://scholar.google.com/scholar_lookup?title=Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia&author=Porter D L&author=Levine B L&author=Kalos M&publication_year=2011&journal=N Engl J Med&volume=365&pages=725-733
[5]
Borghaei
H,
Paz-Ares
L,
Horn
L, et al.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer.
N Engl J Med,
2015, 373: 1627-1639
CrossRef
PubMed
Google Scholar
http://scholar.google.com/scholar_lookup?title=Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer&author=Borghaei H&author=Paz-Ares L&author=Horn L&publication_year=2015&journal=N Engl J Med&volume=373&pages=1627-1639
[6]
Lee
J H,
Lee
J H,
Lim
Y S, et al.
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma.
Gastroenterology,
2015, 148: 1383-1391.e6
CrossRef
PubMed
Google Scholar
http://scholar.google.com/scholar_lookup?title=Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma&author=Lee J H&author=Lee J H&author=Lim Y S&publication_year=2015&journal=Gastroenterology&volume=148&pages=1383-1391.e6